The Global Naloxone Spray Market is expected to reach USD 1.13 Billion by 2027, according to a new report by Reports and Data. Naloxone Nasal Spray is used for treating an opioid emergency or a likely opioid overdose with symptoms such as breathing problems and severe sleepiness or inability to respond.
Naloxone Nasal Spray is used to reverse the effects of opioid medicines for a temporary period. The medicine in this nasal spray does not affect people who are not exposed to opioid medications. It is necessary to provide emergency medical help to the patient after giving the first dose of the nasal spray. According to the Centers for Disease Control and Prevention, approximately 400,000 people died as a result of an opioid overdose in the period 1999 to 2017. Moreover, on an average, over 130 people in America die every day owing to overdoses involving opioids, a class of drugs that comprise prescription medications like oxycodone, fentanyl, morphine, and hydrocodone, along with illegal drugs including heroin or drugs sold as heroin.
Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/1362
Increase in product launches and approval of new naloxone spray products is anticipated to be a significant driver boosting the growth of the market in the upcoming years. For instance, in April 2019, Pfizer, a major pharmaceutical company, launched a generic nasal spray of naloxone, which is expected to significantly fuel market demand.
Additionally, with an increase in the prevalence of opioid overdoses, several efforts are being taken to make this emergency overdose reversal medication more readily available and accessible to the people who may require it. The FDA has made an unprecedented move to assist manufacturers in pursuing approval for an over-the-counter naloxone spray product and is exploring other ways to increase the availability of naloxone products intended for use in the community. As naloxone is a fairly new product, the high cost associated with this product, coupled with the serious side-effects, may create hindrances in the market growth.
Further key findings from the report suggest
- On the basis of dosage, the 4 mg/actuation is expected to witness a significant growth rate in the forecast period.
- Hospitals dominated the market in 2019 and are estimated to grow at a rate of 22.5% in the forecast period.
- In terms of geography, North America held the largest share in the global naloxone market owing to the growing opioid crises in the region. The U.S. is the dominant market in North America with high incidences of opioid overdose and the increasing prevalence of victims with dependency on opioids and morphine.
- Key participants include Emergent BioSolutions, Pfizer, and Teva Pharmaceuticals Industries Ltd.
- In April 2019, the U.S. Food and Drug Administration on Friday approved Teva Pharmaceutical Industries Ltd. to market generic naloxone nasal spray to treat opioid overdoses.
Order Your Copy Now: https://www.reportsanddata.com/checkout-form/1362
For the purpose of this report, Reports and Data segments the Global Naloxone Spray Market on the basis of dosage, distribution channel, and region:
Dosage Outlook (Revenue, USD Million; 2017-2027)
- 2 mg/actuation
- 4 mg/actuation
Distribution Channel Outlook (Revenue, USD Million; 2017-2027)
- Retail Pharmacies
- Online Pharmacies
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/naloxone-spray-market
Regional Outlook (Revenue, USD Million; 2017-2027)
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370